Please login to the form below

Not currently logged in

The IMC unites health industry professionals to combat antibiotic resistant infections

The coalition has formed a new call to action in addressing the way infections are managed across healthcare systems

The Infection Management Coalition

The Infection Management Coalition (IMC) has launched its White Paper, in a first-of-its-kind call to action, outlining the need for a change in the way infection is detected, monitored, prevented and managed across the NHS, other healthcare systems and wider society.

Having been assembled in January 2021, the IMC has sought to gain support in favour of holistic management and pandemic preparedness, following the impact the COVID-19 pandemic has had on societies and economies worldwide.

The IMC comprises of leading health professionals, the scientific community and industry, working together – with the involvement of the government – with the shared goal of implementing a more cohesive approach to infection management.

The IMC partners are Antibiotic Research UK, the Association of British HealthTech Industries (ABHI), the Association of the British Pharmaceutical Industry (ABPI), BD, bioMérieux, the British In Vitro Diagnostics Association (BIVDA), the British Society for Antimicrobial Chemotherapy (BSAC), Menarini UK, Pfizer UK, Roche Diagnostics UK, Thermo Fisher Scientific and the UK Sepsis Trust.

The Infection Management Coalition White Paper calls for the creation of a healthcare system which is resilient in the face of outbreak and pandemic preparedness, infection prevention, rapid treatment of time-critical viral and bacterial infection, with the aim of delivering effective antimicrobial stewardship (AMS). The White Paper builds on the findings published in The Lancet’s worldwide report on the burden of AMR, and underscores the ways society must collectively commit to delivering transformational change.

Dr Ron Daniels, founder and executive director of UK Sepsis Trust, said: “The COVID-19 pandemic has shone a light on the devastating global health and societal implications an infection can have when there are no available preventative interventions or treatment options.

“It concerns me greatly that the next pandemic may very well be a drug-resistant infection that the UK and its international partners are currently ill-equipped to tackle, despite the huge advances made recently in this space. We must act now to avoid this.”

The recommendations include how crucial support is for healthcare providers in prescribing antimicrobials effectively – from efficient use of care diagnostics to determine if antimicrobials are appropriate, to public health and vaccination programmes in helping to avoid reliance on antimicrobials.

The IMC has called for the development of cohesive policy to support action, which includes working as a united front in publishing holistic infection management plans that include AMR.

The coalition believes that many of the recommendations are attainable within the systems that already exist inside the NHS, government and wider society. It hopes that with a combination of organisational change required to drive these recommendations, the need for major government investment or a complete systems overhaul is significantly reduced.

Article by
Fleur Jeffries

30th March 2022

From: Healthcare



Subscribe to our email news alerts


Add my company
Springer Nature

Operating in 50+ countries, we’re a leading research, educational, and professional publisher dedicated to advancing scientific discovery. Whether you’re looking...

Latest intelligence

Whitepaper: Closing the gap with compelling healthcare communications
Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
Healing the Healers
Because if we do not heal the healers, who is going to heal us?...
The (inevitable) digital transformation of Medical Affairs
It’s not a question of ‘if,’ it’s a question of ‘when.’...